Navigation Links
Soligenix Announces Pricing of Public Offering of Common Stock and Warrants
Date:6/21/2013

PRINCETON, N.J., June 21, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) ("Soligenix" or the "Company"), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today the pricing of a registered public offering of shares of common stock and warrants to purchase common stock.

In connection with the public offering, the Company has entered into definitive agreements with institutional investors and certain members of the Company's management and Board of Directors to sell approximately $7.0 million of the Company's securities, consisting of an aggregate of approximately 6.6 million shares of common stock at a price per share of $1.05 and 5-year warrants to purchase up to approximately 5.0 million shares of common stock with an exercise price of $1.65 per share.

Institutional investors in the offering include, among others, an affiliated fund of Third Security, LLC ("Third Security"), a venture capital firm founded by R.J. Kirk.  In connection with Third Security's investment in the Company, the Company intends to appoint a Third Security designee to the Board of Soligenix.

The Company plans to use the net proceeds from the offering to further develop its product candidates and for general working capital purposes.

Soligenix's two lead product candidates include a proprietary formulation of oral BDP (beclomethasone 17,21-dipropionate) for pediatric Crohn's disease (SGX203), which is currently in a Phase 1 clinical trial, and a novel innate defense regulator (IDR) technology for the treatment of oral Mucositis (SGX942) for which the Company plans to initiate a Phase 2 clinical trial in the second half of 2013.

Maxim Group LLC served as placement agent for the offering.

The securities described above were offered
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Grants Soligenix "Fast Track" Designation for SGX942 for the Treatment of Oral Mucositis in Patients with Head and Neck Cancer
2. Soligenix Initiates Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohns Disease
3. Soligenix Reports First Quarter 2013 Financial Results and Highlights Recent Accomplishments
4. Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
5. Soligenix to Present at World Vaccine Congress & Expo
6. Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis
7. Soligenix to Present at 15th Annual BIO CEO & Investor Conference
8. Soligenix Announces Formation of Oral Mucositis Medical Advisory Board
9. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
10. Soligenix Reports Third Quarter 2012 Financial Results and Highlights Recent Accomplishments
11. FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 2015 In der klinischen Studie ... tägliche Einnahme des L. reuteri ... und die Darmproduktion von Proteinfaktoren verändert, die ... tägliche Einnahme von Nutraceutix, L. reuteri ... der patentierten Verabreichungstechnologie BIO- tract ®, die ...
(Date:7/29/2015)... Commenting on GSK,s Q2 performance, the first ... reveals sales rose during the period and that ... Ahead of a November R&D update day he reiterates ... interview and transcript are available now on http://video.merchantcantos.com ... webcasts with senior company executives. If you would like ...
(Date:7/29/2015)... 2015  Henry Schein, Inc. (NASDAQ: HSIC ... products and services to office-based dental, animal health ... financial results. Net sales for the ... an increase of 0.5% compared with the second ... in local currencies and a 7.0% decline related ...
Breaking Medicine Technology:Klinischer Nachweis erbracht, dass L. reuteri Probiotikum von Nutraceutix den Darm-Insulinmetabolismus moduliert 2Henry Schein Reports Record Second Quarter Results 2Henry Schein Reports Record Second Quarter Results 3Henry Schein Reports Record Second Quarter Results 4Henry Schein Reports Record Second Quarter Results 5Henry Schein Reports Record Second Quarter Results 6Henry Schein Reports Record Second Quarter Results 7Henry Schein Reports Record Second Quarter Results 8Henry Schein Reports Record Second Quarter Results 9Henry Schein Reports Record Second Quarter Results 10Henry Schein Reports Record Second Quarter Results 11Henry Schein Reports Record Second Quarter Results 12Henry Schein Reports Record Second Quarter Results 13Henry Schein Reports Record Second Quarter Results 14Henry Schein Reports Record Second Quarter Results 15Henry Schein Reports Record Second Quarter Results 16Henry Schein Reports Record Second Quarter Results 17Henry Schein Reports Record Second Quarter Results 18Henry Schein Reports Record Second Quarter Results 19Henry Schein Reports Record Second Quarter Results 20Henry Schein Reports Record Second Quarter Results 21Henry Schein Reports Record Second Quarter Results 22Henry Schein Reports Record Second Quarter Results 23Henry Schein Reports Record Second Quarter Results 24Henry Schein Reports Record Second Quarter Results 25
(Date:7/29/2015)... ... July 29, 2015 , ... " mybody ” was featured ... small, medium and large businesses making an impact in their industry. Andrew Tropeano, the ... how these advanced probiotic skincare products are designed to strengthen the skin’s defense system ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... ., a global provider of life insurance, annuities, employee benefits and asset management, ... Carolina inclusive sporting event taking place in Charlotte, North Carolina on October ...
(Date:7/29/2015)... Hoffman Estates, IL (PRWEB) , ... July 29, 2015 , ... ... can both benefit from two new products on Mercola.com: a vertical “garden tower” and ... – which can be squeezed into small corners on a porch, balcony, or rooftop ...
(Date:7/29/2015)... ... 2015 , ... One of the world’s leading experts on ... lifesaving impact of removing aluminum from Alzheimer’s disease patients, announced the Children’s ... on a successful pilot study published in The Journal of Alzheimer’s Disease in ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... has launched a chewable version of its EndoMune Jr. probiotic supplement for children ... all-natural supplement that children can enjoy to maintain a healthy balance of beneficial ...
Breaking Medicine News(10 mins):Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3
... UT Southwestern Medical Center surgeons have removed a ... incision in the bellybutton rather than the traditional four ... operation in North Texas. , It went better than ... surgery, who completed the 80-minute procedure with Dr. J. ...
... Honor US Firefighter Scott Ellis for His Comeback from, Ostomy Surgery, and ... ... Expedition, WASHINGTON, Feb. 27 Scott Ellis, a ... evening at a ceremony in Washington, D.C. Founded in,1984 by former San ...
... Former Arkansas,Governor and Presidential Candidate Mike Huckabee accepted ... Debate to be held on Monday,March 3, 2008. ... the debate which would also include Senator John ... to discussing the issues that are important to ...
... MIAMI, Feb. 27 Novartis and Sony Pictures ... "SER," a breast cancer prevention and early detection ... campaign combines,Novartis, resources and expertise in oncology and ... in their fight against breast cancer.,The campaign is ...
... WASHINGTON, Feb. 27 Today, the U.S. House,Foreign ... of,PEPFAR, the U.S. Global Leadership Against HIV/AIDS, Tuberculosis, ... of Family Research Council, released the,following statement:, ... passing an HIV/AIDS,bill free of troubling provisions contained ...
... The UCLA Department of Family Medicine, with support from the ... Research on Health and Healthcare, a group that will study ... , The network will also mentor and develop a ... disparities. , The new group to ...
Cached Medicine News:Health News:UT Southwestern surgeons complete North Texas' first single-incision gallbladder removal 2Health News:UT Southwestern surgeons complete North Texas' first single-incision gallbladder removal 3Health News:Great Comebacks(R) Program Announces 2007 National Award Winner 2Health News:Great Comebacks(R) Program Announces 2007 National Award Winner 3Health News:Great Comebacks(R) Program Announces 2007 National Award Winner 4Health News:Great Comebacks(R) Program Announces 2007 National Award Winner 5Health News:Novartis and Sony Pictures Television International's Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America 2Health News:Novartis and Sony Pictures Television International's Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America 3Health News:Novartis and Sony Pictures Television International's Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America 4Health News:UCLA launches network to study health care disparities affecting minorities 2
... to 350 Liters of pure water, Complete, ... of Purified Water,Millipores compact S.D.S. Storage and ... to 350 liters of purified water produced ... maintain consistent purity of stored water, provide ...
... of pure water, Complete, Compact Systems for ... compact S.D.S. Storage and Distribution Systems are ... of purified water produced by Elix or ... of stored water, provide effective protection against ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
... a range of Milli-Q ultrapure water ... quality requirements. Each of the five ... specifically target contaminants detrimental to particular ... and ICP-MS. The systems incorporate a ...
Medicine Products: